M, C., D, T., A, K., P, F., RM, S., A, M., . . . E, F. (2023). Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis. RMD open, 9(2), . https://doi.org/10.1136/rmdopen-2023-003042
Chicago Style (17th ed.) CitationM, Cardner, Tuckwell D, Kostikova A, Forrer P, Siegel RM, Marti A, Vandemeulebroecke M, and Ferrero E. "Analysis of Serum Proteomics Data Identifies a Quantitative Association Between Beta-defensin 2 at Baseline and Clinical Response to IL-17 Blockade in Psoriatic Arthritis." RMD Open 9, no. 2 (2023). https://doi.org/10.1136/rmdopen-2023-003042.
MLA (9th ed.) CitationM, Cardner, et al. "Analysis of Serum Proteomics Data Identifies a Quantitative Association Between Beta-defensin 2 at Baseline and Clinical Response to IL-17 Blockade in Psoriatic Arthritis." RMD Open, vol. 9, no. 2, 2023, https://doi.org/10.1136/rmdopen-2023-003042.